Beam Therapeutics Inc (BEAM) — Financial Flexibility Index
Beam Therapeutics Inc (BEAM) has a Financial Flexibility Index of -0.40x as of March 2026. Free cash flow of $-126.28 Million (operating CF $-128.51 Million minus capex $2.23 Million) represents 0% of total liabilities ($316.36 Million). Check Beam Therapeutics Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beam Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Beam Therapeutics Inc across 9 annual periods. See BEAM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Beam Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Beam Therapeutics Inc. For the full company profile including market capitalisation, see Beam Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.36x | $-330.16 Million | $-345.10 Million | $242.82 Million | ▼ -48.8% |
| 2024 | -0.91x | $-338.30 Million | $-347.25 Million | $370.28 Million | ▼ -278.5% |
| 2023 | -0.24x | $-115.46 Million | $-149.19 Million | $478.38 Million | ▼ -305.4% |
| 2022 | 0.12x | $71.48 Million | $22.53 Million | $608.24 Million | ▲ +491.2% |
| 2021 | -0.03x | $-19.46 Million | $-66.27 Million | $647.72 Million | ▲ +92.2% |
| 2020 | -0.39x | $-79.38 Million | $-95.74 Million | $206.12 Million | ▲ +64.3% |
| 2019 | -1.08x | $-59.48 Million | $-72.00 Million | $55.15 Million | ▼ -395.9% |
| 2018 | -0.22x | $-7.17 Million | $-20.30 Million | $32.98 Million | ▲ +39.3% |
| 2017 | -0.36x | $-2.36 Million | $-2.71 Million | $6.58 Million | — |